Clinical Trials on 转甲状腺素蛋白淀粉样变性心脏病 in Korea, Democratic People's Republic of
总计180个结果
-
Seoul National University HospitalPharos iBio Co., Ltd.招聘中
-
Samsung Medical Center未知
-
Samsung Medical Center未知
-
Konkuk University Medical CenterChonbuk National University Hospital; Samsung Medical Center; Pusan National University Hospital; Seoul National University Hospital 和其他合作者主动,不招人
-
Ulsan University HospitalThe Korean Society of Hematology, AML/MDS Working Party未知
-
Asan Medical Center终止白血病,慢性粒细胞 | 骨髓性白血病,慢性,慢性期 | 骨髓性白血病,慢性,加速期大韩民国
-
Asan Medical CenterKorea Research Institute of Bioscience & Biotechnology未知
-
Novartis Pharmaceuticals完全的
-
Ulsan University HospitalThe Korean Society of Hematology CML working party未知
-
Seoul St. Mary's HospitalBristol-Myers Squibb未知
-
Samsung Medical CenterJin Yang Pharmaceutical暂停
-
Seoul St. Mary's HospitalNovartis未知
-
Seoul St. Mary's HospitalNovartis未知
-
Pusan National University Hospital完全的
-
Seoul St. Mary's HospitalMinistry of Health & Welfare, Korea未知
-
Seoul St. Mary's HospitalJanssen, LP未知
-
The Korean Society of Blood and Marrow TransplantationChonbuk National University Hospital; Samsung Medical Center; Seoul St. Mary's Hospital; Pusan National... 和其他合作者终止
-
Asan Medical Center主动,不招人
-
Cooperative Study Group A for Hematology未知
-
Chong Kun Dang Pharmaceutical完全的
-
Korea Otsuka Pharmaceutical Co., Ltd.主动,不招人
-
Asan Medical Center完全的
-
Asan Medical CenterKorea Research Institute of Bioscience & Biotechnology完全的
-
Neurozen Inc.Chonnam National University Hospital; Chosun University Hospital完全的
-
Eidos Therapeutics, a BridgeBio company主动,不招人淀粉样变性心肌病,转甲状腺素蛋白相关美国, 西班牙, 澳大利亚, 加拿大, 意大利, 荷兰, 爱尔兰, 新西兰, 比利时, 以色列, 希腊, 大韩民国, 捷克语, 巴西, 丹麦, 葡萄牙, 英国